Whole blood gene expression in infants with respiratory syncytial virus bronchiolitis

Hans-Olav Fjaerli1, Geir Bukholm, Anne Krog

  • 1University of Oslo, Faculty Division Akershus University Hospital, Department of Paediatrics, Akershus University Hospital, Norway. h.o.fjarli@medisin.uio.no

BMC Infectious Diseases
|December 15, 2006
PubMed

Insights

Respiratory syncytial virus (RSV) bronchiolitis in infants shows distinct gene expression patterns. Interferon alpha-inducible protein 27 (IFI27) was upregulated, while Charcot-Leyden crystal protein (CLC) was downregulated in affected infants.

Area of Science:

  • Immunology
  • Virology
  • Pediatrics

Background:

  • Respiratory syncytial virus (RSV) is a leading cause of infant bronchiolitis globally.
  • Disease severity is influenced by environmental, viral, and host factors.
  • Understanding the host's systemic response is crucial for managing RSV infections.

Purpose of the Study:

  • To investigate gene expression differences in infants with RSV bronchiolitis compared to healthy controls.
  • To identify specific genes associated with the host response to RSV infection.

Main Methods:

  • Microarray technology was used to measure mRNA gene expression in whole blood.
  • Gene expression levels were validated using quantitative real-time polymerase chain reaction (QRT-PCR).
  • Study included hospitalized infants with RSV bronchiolitis and age-matched controls.

Main Results:

  • Nearly 50% of the top 30 differentially expressed genes were related to immunological processes.
  • Interferon, alpha-inducible protein 27 (IFI27) showed significant upregulation.
  • Charcot-Leyden crystal protein (CLC) was found to be significantly downregulated.
  • QRT-PCR confirmed IFI27 upregulation and CLC downregulation in the majority of infants.

Conclusions:

  • IFI27 is upregulated and CLC is downregulated in infants hospitalized with RSV bronchiolitis.
  • These specific gene expression changes in response to RSV require further investigation.
  • Elucidating the specificity of these gene expressions is important for understanding host response in moderate bronchiolitis.
Abstract

Related Concept Videos

Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
Common Respiratory Disorders01:31

Common Respiratory Disorders

Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...